Saama Positioned as a Luminary in “Innovation Watch: AI Applications in Clinical Development 2026” by Everest Group
Everest Group’s Innovation Watch: AI Applications in Clinical Development 2026 has positioned Saama as a Luminary among 18 assessed clinical development AI providers. This assessment evaluates providers based on their impact created in the market (adoption and maturity) and ecosystem drivers (partnerships and investments).
Some of Saama’s strengths, outlined in the report, include:
- High Capability Maturity: Saama is recognized for its AI applications, reflecting its success in advancing AI tools beyond the pilot phase into full-scale production.
- Pioneering Agentic AI Frameworks: The report highlights Saama’s use of Agentic AI frameworks within its clinical data and analytics products to automate complex workflows and enable autonomous decision-making.
- SDTM and ADaM Automation: Saama’s SDTM Navigator and ADaM Navigator modules are recognized for using AI to automate the conversion of raw clinical data into standardized regulatory formats, significantly reducing manual effort and cycle times.
- Generative AI-Powered Insights: With Medical Lens, Saama provides generative AI-powered literature reviews, enabling users to ask natural-language questions and receive rapid summaries of competitive trials or sponsor documents.
- Biometrics Productivity: The Biometrics Platform focuses on improving the productivity of statistical programmers through AI-specific capabilities, such as an SDTM copilot and automated dependency graph creation.
Everest Group’s Innovation Watch: AI Applications in Clinical Development 2026 has positioned Saama as a Luminary among 18 assessed clinical development AI providers. This assessment evaluates providers based on their impact created in the market (adoption and maturity) and ecosystem drivers (partnerships and investments).
Explore the Everest Group summary for key insights on Saama’s AI leadership.
